ARCHIVES

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

This article is from The Cancer Letter archive.

Vol. 31 No. 19 | May 13, 2005

Download PDF Visit The Full Archive

Related Articles

NAS Report Advises Candidates on Filling Key Science Positions.

October 31, 2008

ACCC Established FCCC Special Interest Group

April 11, 1986

Omnibus bill recissions would cut $28 million from NCI FY04 budget.

January 9, 2004

Phase III Cyramza Trial Meets OS Primary Endpoint

September 26, 2014

Anna Barker Named Deputy Director for Strategic Scientific Initiatives

December 6, 2002

Cancer Prevention: NSABP Publishes P-1 Data, Finds Risk Of Breast Cancer Cut By 49 Percent

September 18, 1998